Get started
Author

Kepa Elorriaga

Observed names: Elorriaga Kepa, Elorriaga, Kepa, K Elorriaga, K. Elorriaga
Institution: Onkologikoa
OpenAlex ID: A5066910733
Sox2 expression in breast tumours and activation in breast cancer stem cells
2011 · O Leis, A Eguiara, et al. · Oncogene · 525
Impact of age- and gender-specific cut-off values for the fecal immunochemical test for hemoglobin in colorectal cancer screening
2016 · Cristina Alvarez-Urturi, Montserrat Andreu, et al. · Digestive and Liver Disease · 31
Mutational profiling can identify laryngeal dysplasia at risk of progression to invasive carcinoma
2018 · Lorea Manterola, Pablo Aguirre, et al. · Scientific Reports · 30
PDF
Molecularly determined total tumour load in lymph nodes of stage I–II colon cancer patients correlates with high-risk factors. A multicentre prospective study
2016 · Iban Aldecoa, Begoña Atares, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 25
PDF
Micropapillary transitional cell carcinoma of the urinary bladder
1999 · J I López, K Elorriaga, et al. · Histopathology · 21
Rate of Detection of Advanced Neoplasms in Proximal Colon by Simulated Sigmoidoscopy vs Fecal Immunochemical Tests
2014 · Antoni Castells, Enrique Quintero, et al. · Clinical Gastroenterology and Hepatology · 19
Células madre tumorales: una diana terapéutica en el cáncer de mama
2012 · Arrate Eguiara, Kepa Elorriaga, et al. · Revista de Senología y Patología Mamaria · 16
A prospective study on tumour response assessment methods after neoadjuvant endocrine therapy in early oestrogen receptor-positive breast cancer
2024 · Joanna I. López-Velazco, Sara Manzano, et al. · Breast Cancer Research · 13
PDF
Colonic mucosal Schwann cell hamartoma
2020 · María Vaamonde‐Lorenzo, Kepa Elorriaga, et al. · Journal of Digestive Diseases · 7
Molecular characterisation of the residual disease after neoadjuvant endocrine therapy in ER+/HER2- breast cancer uncovers biomarkers of tumour response
2025 · Joanna I. López-Velazco, Sara Manzano, et al. · Translational Oncology · 4
Hormone receptors and HER2 expression in primary tumor and synchronous axillary lymph node metastasis in estrogen receptor positive breast cancer.
2015 · Isabel Alvarez, Ricardo Rezola, et al. · Journal of Clinical Oncology · 2
Obstrucción intestinal en una mujer previamente sana
2002 · Iñaki Torre, Alfonso Gutiérrez-Macías, et al. · Enfermedades Infecciosas y Microbiología Clínica · 2
Correspondence re: Casey M, Rosenblatt R, Zimmerman J, Fineberg S. Mastectomy without malignancy after carcinoma diagnosed by large-core stereotactic breast biopsy. Mod Pathol 1997;10:1209-13.
1998 · J I López, T Ibañez, et al. · PubMed · 2
96P PAM50-based ROR indexes as a tool to individualize the use of neoadjuvant endocrine therapy in ER+/HER2- breast cancer
2022 · J.I. Lopez Velazco, S. Manzano, et al. · Annals of Oncology · 1
PDF
Molecular Characterisation of the Residual Disease after Neoadjuvant Endocrine Therapy in Er+/Her2- Breast Cancer Uncovers Biomarkers of Tumour Response
2025 · Joanna I. López-Velazco, Sara Manzano, et al. · SSRN Electronic Journal
Molecular characterization of the residual disease after neoadjuvant endocrine therapy in ER+/HER2- breast cancer uncovers biomarkers of tumour response
2024 · Joanna I. López-Velazco, Sara Manzano, et al. · Research Square
PDF
Molecular Characterisation of the Residual Disease after Neoadjuvant Endocrine Therapy in Er+/Her2- Breast Cancer Uncovers Biomarkers of Tumour Response
2024 · Joanna I. López-Velazco, Sara Manzano, et al. · SSRN Electronic Journal
Abstract P2-15-01: Conversion from luminal to normal intrinsic subtype by PAM50 after neoadjuvant endocrine therapy is associate with biomarkers of good prognosis in luminal breast cancer
2022 · Joanna Ines Lopez Velazco, María Otaño, et al. · Cancer Research
Abstract PS5-39: Tumour cellularity size as a biomarker to predict response after neoadjuvant endocrine therapy: Correlation analysis between Ki67 expression and PEPI score
2021 · Joanna Ines Lopez Velazco, María Otaño, et al. · Cancer Research
110P Primary endocrine therapy of breast cancer: Is there a good radiological technique to define pathological response?
2020 · J.I. Lopez Velazco, M. Otaño, et al. · Annals of Oncology
PO-085 Mutational profiling can identify laryngeal dysplasia at risk of progression to invasive carcinoma
2018 · L. Manterola, P. Aguirre, et al. · ESMO Open
Abstract 426: Sox2 expression in breast cancer stem cells: Possible mechanisms
2012 · Olatz Leis Esnaola, Arrate Eguiara, et al. · Cancer Research
Works count: 24
Citation count: 698
H-index: 8
I10-index: 8
Year
Topic
Type